TIANYANG QI
Inventor
Stats
- 0 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 4 US Applications Filed
- 3 Total Citation Count
- Jun 10, 2022 Most Recent Filing
- Feb 17, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NOKIA SOLUTIONS AND NETWORKS OY | 1
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| Pingshan District, Shenzhen, Guangdong, CN | Nov 07, 24 - Nov 07, 24 |
| Shenzhen, CN | Oct 26, 23 - Sep 26, 24 |
| Zhejiang, CN | Feb 08, 18 - Feb 08, 18 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
| C07F: | ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0368,209 | 2024 | GEMCITABINE ANTICANCER DERIVATIVE AND ANTICANCER PHARMACEUTICAL USE | 0 |
| 2024/0316,079 | 2024 | USE OF AKR1C3-ACTIVATED COMPOUND | 0 |
| 2023/0339,991 | 2023 | HYPOXIA-ACTIVATED DNA ALKYLATING AGENT AND MEDICAL USE THEREOF | 0 |
| 2018/0042,032 | 2018 | A Method for Resource Release | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.